Key result
Single-cell transcriptomics stratifies microscopic polyangiitis into relapse-prone and treatment-responsive phenotypes via CD14+ monocytes.
Observational
Identifies immune phenotypes associated with treatment response in microscopic polyangiitis, suggesting targeted therapies.
The immunological basis of the clinical heterogeneity in autoimmune vasculitis remains poorly understood. In this study, we conduct single-cell transcriptome analyses on peripheral blood mononuclear cells (PBMCs) from newly-onset patients with microscopic polyangiitis (MPA). Increased proportions of activated CD14 + monocytes and CD14 + monocytes expressing interferon signature genes (ISGs) are distinctive features of MPA. Patient-specific analysis further classifies MPA into two groups. The MPA-MONO group is characterized by a high proportion of activated CD14 + monocytes, which persist before and after immunosuppressive therapy. These patients are clinically defined by increased monocyte ratio in the total PBMC count and have a high relapse rate. The MPA-IFN group is characterized by a high proportion of ISG + CD14 + monocytes. These patients are clinically defined by high serum interferon-alpha concentrations and show good response to immunosuppressive therapy. Our findings identify the immunological phenotypes of MPA and provide clinical insights for personalized treatment and accurate prognostic prediction.
No takes yet. Share an insight, caveat, or question.
Nishide et al. (2023) conducted an observational in Microscopic polyangiitis (MPA). Immunological phenotypes (MPA-MONO vs MPA-IFN) was evaluated on Immunological phenotypes and clinical characteristics. Single-cell transcriptome analysis classified newly-onset microscopic polyangiitis into MPA-MONO (high relapse rate) and MPA-IFN (good response to therapy) phenotypes based on CD14+ monocyte signatures.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: